
### [NCIT:C9410](http://purl.obolibrary.org/obo/NCIT_C9410)
**Label:** Epithelioid Sarcoma NCI Grade 3

**Subclasses:** 

**Class expressions from DL-Learner:**

- Thing 53.67%
- [NCIT:C45809](http://purl.obolibrary.org/obo/NCIT_C45809) (Gain of Chromosome 11q13) 52.38%
- [NCIT:C36564](http://purl.obolibrary.org/obo/NCIT_C36564) (i(8)(q10)) 52.38%
- [NCIT:C36506](http://purl.obolibrary.org/obo/NCIT_C36506) (Loss of Chromosome 22q) 52.38%
- [NCIT:C36503](http://purl.obolibrary.org/obo/NCIT_C36503) (Loss of Chromosome 8p) 52.38%
- [NCIT:C36163](http://purl.obolibrary.org/obo/NCIT_C36163) (Metastatic/Recurrent Disease) 52.38%
- [NCIT:C36129](http://purl.obolibrary.org/obo/NCIT_C36129) (High Grade Lesion) 52.38%
- [NCIT:C36105](http://purl.obolibrary.org/obo/NCIT_C36105) (Indolent Clinical Course) 52.38%
- [NCIT:C36104](http://purl.obolibrary.org/obo/NCIT_C36104) (Aggressive Clinical Course) 52.38%
- [NCIT:C28079](http://purl.obolibrary.org/obo/NCIT_C28079) (Grade 3) 52.38%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) 37.74%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 37.74%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 37.74%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 37.74%
- [NCIT:C53665](http://purl.obolibrary.org/obo/NCIT_C53665) (Intermediate Filaments Present) and (not ([NCIT:C40156](http://purl.obolibrary.org/obo/NCIT_C40156) (Endometrial Undifferentiated Carcinoma))) 37.74%


